11-32392019-C-G
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM1PM2PM5PP3_ModeratePP5_Moderate
The NM_024426.6(WT1):c.1400G>C(p.Arg467Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R467L) has been classified as Uncertain significance.
Frequency
Consequence
NM_024426.6 missense
Scores
Clinical Significance
Conservation
Publications
- Denys-Drash syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, G2P
 - Wilms tumor 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae)
 - familial idiopathic steroid-resistant nephrotic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - Frasier syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| WT1 | ENST00000452863.10  | c.1400G>C | p.Arg467Pro | missense_variant | Exon 9 of 10 | 1 | NM_024426.6 | ENSP00000415516.5 | 
Frequencies
GnomAD3 genomes  Cov.: 32 
GnomAD4 exome Cov.: 31 
GnomAD4 genome  Cov.: 32 
ClinVar
Submissions by phenotype
Drash syndrome    Pathogenic:1 
- -
WT1-related disorder    Pathogenic:1 
The WT1 c.1385G>C variant is predicted to result in the amino acid substitution p.Arg462Pro. This variant is alternatively referred to as p.Arg394Pro using Legacy nomenclature. It is also referred to as NM_024426.6:c.1400G>C (p.Arg467Pro) using an updated version of this transcript. This variant has been reported in individuals with Denys-Drash syndrome (Fig. 3, Bruening et al. 1992. PubMed ID: 1302008; Table S1, Lehnhardt. 2015. PubMed ID: 25818337). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Alternate nucleotide changes affecting the same amino acid (p.Arg462Gln, p.Arg462Gly, p.Arg462Leu, and p.Arg462Trp) have been reported in individuals with WT1-related disease (Table 1, Pelletier et al. 1991. PubMed ID: 1655284; Jeanpierre et al. 1998. PubMed ID: 9529364; Royer-Pokora et al. 2004. PubMed ID: 15150775; Table 1, Chernin et al. 2010. PubMed ID: 20595692; Table S1, Lehnhardt. 2015. PubMed ID: 25818337). Of note, the alternate p.Arg462Trp (aka p.Arg467Trp) change is reported to be a hotspot variant for Denys-Drash syndrome (Table 6, Lipska-Zietkiewicz et al. 2020. PubMed ID: 32352694). The c.1385G>C (p.Arg462Pro) variant is interpreted as pathogenic. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at